Adenomas ≥ 28 mm, bilaterally located tumors, or presence of low ACTH values at diagnosis were found to be associated with newly diagnosed ACS over time, so a long-term follow-up may be recommended in AI patients with these characteristics. This evidence concerns the gene POMC and adenoma.